(IN BRIEF) Researchers from the Luxembourg Institute of Health’s NORLUX Neuro-Oncology Laboratory have contributed to an international study published in Nature that sheds new light on how adult brain tumours, particularly IDH-mutant gliomas, evolve and become more aggressive after treatment. … Read the full press release →
Posted in Artificial Intelligence (AI), Education, European Union, Healthcare, Luxembourg, Pharma & Biotech, Science, Technology
Tagged adult brain tumours, brain cancer, brain tumours, C20/BM/14646004/GLASSLUX, cancer cells, cancer research, chemotherapy, Department of Cancer Research, Dr Anna Golebiewska, FNR, genomic technologies, GLASSLUX, glioma recurrence, IDH inhibitors, IDH-mutant gliomas, immature cancer cells, INTER/TRANSCAN22/17612718/PLASTIG, international research consortium, LIH, LIH NORLUX Lab Contributes to Nature Study Advancing Understanding of Brain Tumour Evolution and Recurrence, LIH NORLUX Lab Contributes to Nature Study Revealing How Brain Tumours Become More Aggressive Over Time, longitudinal tumour samples, Luxembourg Institute of Health, Luxembourg National Research Fund, nature, Nature Study with LIH NORLUX Contribution Identifies Biological Pathways Driving Brain Tumour Progression, neuro-oncology, NORLUX Lab Contributes Rare Patient Samples and Preclinical Models to Major Study on Glioma Recurrence, NORLUX Neuro-Oncology Laboratory, patient-derived preclinical models, personalised treatment, PLASTIG, PRECISION-PDX cohort, radiotherapy, single-cell technologies, therapy resistance, tumour environment, tumour evolution, tumour progression
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
